SCHEMBL12316865

SCHEMBL12316865

c1cc(-c2ccc3nsnc3c2)c2cc3nsnc3cc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDO2 P48775 1/20 0.50
PTPN11 Q06124 2/20 0.39
TLR8 Q9NR97 1/20 0.35
TXNRD1 Q16881 1/20 0.34
TXNRD3 Q86VQ6 1/20 0.34
TXNRD2 Q9NNW7 1/20 0.34
TGFBR1 P36897 10/20 0.34
MAPK14 Q16539 7/20 0.34
PTPN1 P18031 1/20 0.33
DHFR P00374 1/20 0.33
ALDH1A1 P00352 2/20 0.32
MAPT P10636 2/20 0.32
MCL1 Q07820 1/20 0.32
ACMSD Q8TDX5 1/20 0.32
NPC1 O15118 1/20 0.32
POLB P06746 1/20 0.32
HPGD P15428 1/20 0.32
RAB9A P51151 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3858998 0.73 PTPN11 (0.58) TDO2PTPN11TXNRD1TXNRD3TXNRD2
SCHEMBL18292318 0.71 HSD17B10 (0.62) TDO2ALDH1A1MAPTPOLBHPGD
SCHEMBL14451021 0.69 DHFR (0.52) TDO2PTPN1DHFRALDH1A1NPC1
SCHEMBL4017762 0.69 TDO2 (0.52) TDO2PTPN11TXNRD1TXNRD3TXNRD2
SCHEMBL12096807 0.69 NQO2 (0.55) TDO2PTPN11TXNRD1TXNRD3TXNRD2
SCHEMBL30570983 0.68 TDO2 (0.48) TDO2PTPN11TGFBR1ALDH1A1MAPT
SCHEMBL28341419 0.65 GSTP1 (0.52) TLR8DHFRALDH1A1MCL1ACMSD
SCHEMBL537003 0.64 ALDH1A1 (0.44) TLR8ALDH1A1MAPTMCL1ACMSD
SCHEMBL23143311 0.63 PIK3CA (0.47) TDO2PTPN11TXNRD1TXNRD3TXNRD2
SCHEMBL1041948 0.63 GSTP1 (0.55) DHFRALDH1A1MCL1ACMSDHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8263642-B2 Antimicrobial compounds and methods of use thereof VANDERBILT UNIVERSITY (US) 2012-09-11 US disclosed
US-8263642-B2 Antimicrobial compounds and methods of use thereof VANDERBILT UNIVERSITY (US) 2012-09-11 US disclosed
US-20100004324-A1 ANTIMICROBIAL COMPOUNDS AND METHODS OF USE THEREOF VANDERBILT UNIVERSITY 2010-01-07 US disclosed
US-20100004324-A1 ANTIMICROBIAL COMPOUNDS AND METHODS OF USE THEREOF VANDERBILT UNIVERSITY 2010-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004324-A1 ANTIMICROBIAL COMPOUNDS AND METHODS OF USE THEREOF HMOX1, HMOX2, NOD2 TDO2 140/4885PTPN11 3568/4885TLR8 43/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.